BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083

  September 3, 2014

   · 

  3 min read
• Biotech Beach

  Cidara Therapeutics To Present Data From Antifungal Drug Development Program At ICAAC

  September 3, 2014

   · 

  1 min read
• Business

  Palatin Technologies Licenses Bremelanotide In Europe And Other Selected Countries To Gedeon Richter Ltd.

  September 3, 2014

   · 

  6 min read
• Business

  RuiYi (formerly Anaphore) Appoints Mark Saad Chief Financial Officer

  September 3, 2014

   · 

  3 min read
• Policy

  Takeda Responds To Judgment In Diabetes Drug Case

  September 3, 2014

   · 

  6 min read
• Business

  Pacific Edge Diagnostics U.S.A LTD Release: Cxbladder User Program Research Agreement Signed With Kaiser PermanenteSouthern California

  September 3, 2014

   · 

  4 min read
• Drug Development

  Halozyme Therapeutics, Inc.'s PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation

  September 3, 2014

   · 

  3 min read
• Business

  RegeneRx Biopharmaceuticals, Inc. Receives $1 Million Pursuant To Product License And Stock Purchase Agreement

  September 3, 2014

   · 

  2 min read
• Deals

  Albemarle Corporation Completes Sale Of Antioxidant, Ibuprofen And Propofol Businesses To SI Group

  September 3, 2014

   · 

  1 min read
• Drug Development

  GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach To Treat Multiple Sclerosis

  September 3, 2014

   · 

  1 min read